Literature DB >> 10809909

Acute neurological stroke care in Europe: results of the European Stroke Care Inventory.

M Brainin1, N Bornstein, G Boysen, V Demarin.   

Abstract

Following the 1997 Recommendations of the EFNS Task Force on Acute Neurological Stroke Care (European Journal of Neurology, 1997: 4:435-441) a European Inventory was undertaken to assess the development of acute stroke care in the EFNS member countries and to give an estimate of the needs based on 1997 data. All 30 members of the EFNS Stroke Scientist Panel were asked to complete a questionnaire on acute stroke epidemiology as well as acute stroke care in their country. Data were based either on national surveys, hospital statistics, or estimates given on the basis of extrapolation of regional studies, or other defined sources. Specialist estimates were also taken into account where no other data source was available. Data from 22 countries were received and referred to almost one million strokes occurring per year in a population of over 500 million. Most epidemiological data confirmed an east-west gap known from previous studies. These included rates that, in eastern countries, were higher for incidence, stroke as a leading cause of death, and 30-day case-fatality, and rates that were lower for overall hospitalization or availability of CT scanning. East-west differences were not seen for the total number of acute stroke units or the number of acute stroke units set up within neurological hospital departments, nor for most other quality indicators of acute stroke care with the exception of technological standards in some countries. The higher rates for 30-day case-fatality in eastern Europe (mostly above 20%) compared with western Europe (mostly below 20%) are probably caused by a case mix with more severe ischemic strokes and a higher percentage of cerebral haemorrhages admitted for acute care in eastern Europe. This is probably due to the higher prevalence of the most common risk factors for stroke in these countries which tend to result in more severe strokes. This, therefore, underlines the need for stroke prevention programmes especially in eastern Europe. This epidemiological east-west gap is not reflected by most quality indicators for acute stroke care, e.g. total number of acute stroke units available within each country. Most eastern European countries have a well-developed neurological care system for acute stroke but still have urgent technological and socioeconomical needs. The leading role of clinical neurology in acute stroke care is visible in most but not all European countries.

Entities:  

Mesh:

Year:  2000        PMID: 10809909     DOI: 10.1046/j.1468-1331.2000.007001005.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  15 in total

1.  The incidence of stroke and transient ischaemic attacks is falling: a report from the Belgian sentinel stations.

Authors:  Frank Buntinx; Dirk Devroey; Viviane Van Casteren
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

2.  [Recommendations of the European Stroke Initiative (EUSI) for treatment of ischemic stroke--update 2003. I. organization and acute therapy].

Authors:  Sonja Külkens; Peter Arthur Ringleb; Werner Hacke
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

3.  [Ebrictus study. Functional results, survival, and potential years of life lost after the first stroke].

Authors:  J L Clua-Espuny; J L Piñol-Moreso; A Panisello-Tafalla; J Lucas-Noll; V F Gil-Guillen; D Orozco-Beltran; M L Queralt-Tomas
Journal:  Aten Primaria       Date:  2011-09-28       Impact factor: 1.137

4.  National variations in mortality and functional outcome: should we be worried?

Authors:  D W J Dippel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

5.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack. Part 1].

Authors:  P Ringleb; P D Schellinger; W Hacke
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

6.  Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST).

Authors:  L J Gray; N Sprigg; P M W Bath; P Sørensen; E Lindenstrøm; G Boysen; P P De Deyn; P Friis; D Leys; R Marttila; J-E Olsson; D O'Neill; B Ringelstein; J-J van der Sande; A G G Turpie
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07-26       Impact factor: 10.154

7.  Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.

Authors:  Rebabonye B Pharithi; Deepti Ranganathan; Jim O'Brien; Emmanuel E Egom; Cathie Burke; Daniel Ryan; Christine McAuliffe; Marguerite Vaughan; Tara Coughlan; Edwina Morrissey; John McHugh; David Moore; Ronan Collins
Journal:  Ir J Med Sci       Date:  2018-06-02       Impact factor: 1.568

8.  Controlling patient participation during robot-assisted gait training.

Authors:  Alexander Koenig; Ximena Omlin; Jeannine Bergmann; Lukas Zimmerli; Marc Bolliger; Friedemann Müller; Robert Riener
Journal:  J Neuroeng Rehabil       Date:  2011-03-23       Impact factor: 4.262

9.  Stroke in neurological services in Italy.

Authors:  Fabrizio Antonio de Falco; Maurizio A Leone; Ettore Beghi
Journal:  Neurol Int       Date:  2009-11-16

10.  Effects of intensive arm training with the rehabilitation robot ARMin II in chronic stroke patients: four single-cases.

Authors:  Patricia Staubli; Tobias Nef; Verena Klamroth-Marganska; Robert Riener
Journal:  J Neuroeng Rehabil       Date:  2009-12-17       Impact factor: 4.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.